Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | Y327L |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | TP53 Y327L (also referred to as Y326L) lies within the tetramerization domain of the Tp53 protein (PMID: 15510160). Y327L confers similar sensitivity to mutant Tp53-targeted therapeutics compared to cells with characterized Tp53 mutations in culture (PMID: 26748848), however, has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown. |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 exon9 TP53 Y327L |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7673548_7673549delTAinsCT |
| cDNA | c.979_980delTAinsCT |
| Protein | p.Y327L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001407264.1 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126113 | chr17:g.7673548_7673549delTAinsAG | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001407268.1 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001407270.1 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126113.3 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_000546.5 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126112 | chr17:g.7673548_7673549delTAinsAG | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126112.2 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126113.2 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126114.2 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_000546 | chr17:g.7673548_7673549delTAinsAG | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001126114 | chr17:g.7673548_7673549delTAinsAG | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7673548_7673549delTAinsCT | c.979_980delTAinsCT | p.Y327L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| TP53 Y327L | ovarian carcinoma | sensitive | ReACp53 | Preclinical | Actionable | In a preclinical study, ReACp53 induced cell death in human primary ovarian carcinoma cells harboring TP53 Y327L in culture (PMID: 26748848). | 26748848 |